Supernus Pharmaceuticals (SUPN) Cash from Discontinued Operations (2011)
Supernus Pharmaceuticals' (SUPN) quarterly Cash from Discontinued Operations came in at 120000.0 in Q4 2011, down 109.18% on a QoQ basis from 1307000.0 in Q3 2011.
Supernus Pharmaceuticals (SUPN) Cash from Discontinued Operations (2011) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 1 years of Cash from Discontinued Operations data on file, last reported at 120000.0 in Q4 2011.
- On a quarterly basis, Cash from Discontinued Operations changed N/A year-over-year to 120000.0 in Q4 2011; TTM through Dec 2011 was 2021000.0, a N/A change from a year earlier, with the FY2011 full-year figure at 2021000.0, up 674.15% from the prior year.
- Cash from Discontinued Operations for Q4 2011 stood at 120000.0, down from 1307000.0 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for SUPN reached as high as 1749000.0 in Q1 2011 and fell as low as 915000.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -120,000.00 |
| Dec 31, 2011 | -120,000.00 |
| Sep 30, 2011 | 1.31 Mn |
| Sep 30, 2011 | 1.31 Mn |
| Jun 30, 2011 | -915,000.00 |
| Jun 30, 2011 | -915,000.00 |
| Mar 31, 2011 | 1.75 Mn |
| Mar 31, 2011 | 1.75 Mn |